{"id":435,"date":"2016-06-13T10:58:19","date_gmt":"2016-06-13T08:58:19","guid":{"rendered":"http:\/\/blogs.tu-braunschweig.de\/pubpharm\/?p=435"},"modified":"2019-07-05T09:49:57","modified_gmt":"2019-07-05T07:49:57","slug":"top-fid-zeitschriften-erste-nutzungsstatistiken","status":"publish","type":"post","link":"https:\/\/blog.pubpharm.de\/index.php\/2016\/06\/13\/top-fid-zeitschriften-erste-nutzungsstatistiken\/","title":{"rendered":"Top FID-Zeitschriften &#8211; erste Nutzungsstatistiken"},"content":{"rendered":"<p>F\u00fcr die lizenzierten FID-Zeitschriften gibt es die ersten Nutzungsstatistiken.<br \/>\nDies sind die Top 5 FID-Zeitschriften:<br \/>\n1. Expert Opinion on Drug Delivery (Taylor &amp; Francis)<br \/>\n2. Drug Development and Industrial Pharmacy (Taylor &amp; Francis)<br \/>\n3. Drugs of the Future (Thomson Reuters)<br \/>\n4. Drugs of Today (Thomson Reuters)<br \/>\n5. Pharmaceutical Development and Technology (Taylor &amp; Francis)<br \/>\nIm Zeitraum Sep. bis Dez. 2015 haben Wissenschaftler\/innen aus diesen Zeitschriften die\u00a0 meisten Artikel heruntergeladen. Informationen zum Volltextzugriff auf die vom FID lizenzierten Zeitschriften erhalten Sie unter dem Reiter &#8222;Lizenzierte Zeitschriften&#8220;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>F\u00fcr die lizenzierten FID-Zeitschriften gibt es die ersten Nutzungsstatistiken. Dies sind die Top 5 FID-Zeitschriften: 1. Expert Opinion on Drug Delivery (Taylor &amp; Francis) 2. Drug Development and Industrial Pharmacy (Taylor &amp; Francis) 3. Drugs of the Future (Thomson Reuters) 4. Drugs of Today (Thomson Reuters) 5. Pharmaceutical Development and Technology (Taylor &amp; Francis) Im [&hellip;]<\/p>\n","protected":false},"author":182,"featured_media":1409,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-435","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fid-lizenzen"],"_links":{"self":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/users\/182"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/comments?post=435"}],"version-history":[{"count":1,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/435\/revisions"}],"predecessor-version":[{"id":1458,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/435\/revisions\/1458"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/media\/1409"}],"wp:attachment":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/media?parent=435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/categories?post=435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/tags?post=435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}